Table 5.
Prevalence of and average HbA1c values by cumulative number of metabolic syndrome components
| # of MetS Components | Women | Men | |||
|---|---|---|---|---|---|
| Diabetic | Nondiabetic | Diabetic | Nondiabetic | ||
| 0 | n | 25 (3.6%) | 462 (13.4%) | 55 (7.8%) | 547 (17.6%) |
| HbA1c M ± SE | 7.62 ± 0.32 | 5.34 ± 0.02 | 7.87 ± 0.26 | 5.30 ± 0.02 | |
| 1 | n | 63 (9.0%) | 915 (26.6%) | 116 (16.4%) | 997 (32.1%) |
| HbA1c M ± SE | 7.54 ± 0.19 | 5.41 ± 0.02 | 7.84 ± 0.16 | 5.41 ± 0.01 | |
| 2 | n | 173 (24.6%) | 997 (29.0%) | 232 (32.7%) | 1031 (33.2%) |
| HbA1c M ± SE | 8.01 ± 0.14 | 5.44 ± 0.02 | 8.01 ± 0.13 | 5.49 ± 0.01 | |
| 3 | n | 238 (33.9%) | 770 (22.4%) | 209 (29.5%) | 420 (13.5%) |
| HbA1c M ± SE | 7.83 ± 0.11 | 5.57 ± 0.02 | 8.33 ± 0.14 | 5.55 ± 0.02 | |
| 4 | n | 204 (29.0%) | 295 (8.6%) | 112 (3.6%) | 112 (3.6%) |
| HbA1c M ± SE | 8.14 ± 0.13 | 5.63 ± 0.03 | 8.37 ± 0.18 | 5.59 ± 0.04 | |
| ρ | 0.09 | 0.19 | 0.12 | 0.18 | |
| p | 0.02 * | < 2.2e-16 *** | 0.002 ** | < 2.2e-16 *** | |
Components determined by values that exceed ATP III Metabolic Syndrome criteria thresholds (Table 1)
* p < 0.05; ** p < 0.01; *** p < 0.001